Drug Shortage Report for MYLAN-HYDROXYUREA

Last updated on 2023-01-23 History
Report ID 180346
Drug Identification Number 02242920
Brand name MYLAN-HYDROXYUREA
Common or Proper name HYDROXYUREA
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) HYDROXYUREA
Strength(s) 500MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100BT
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-01-18
Actual start date 2023-01-19
Estimated end date 2023-03-14
Actual end date
Shortage status Actual shortage
Updated date 2023-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-01-23 French Compare
v6 2023-01-23 English Compare
v5 2023-01-19 English Compare
v4 2023-01-17 French Compare
v3 2023-01-17 English Compare
v2 2023-01-10 French Compare
v1 2023-01-10 English Compare

Showing 1 to 7 of 7